68 related articles for article (PubMed ID: 6229096)
1. [Therapy of the surgical menopause syndrome with depot medroxyprogesterone acetate and its objective evaluation testing the reaction of the anterior pituitary gland to stimulation with gonadotropin-releasing hormone].
Boschitsch E; Gitsch E; Spona J
Wien Klin Wochenschr; 1983 Oct; 95(20):718-24. PubMed ID: 6229096
[TBL] [Abstract][Full Text] [Related]
2. [Conservative surgery combined with depot medroxyprogesterone acetate in treatment of moderate or severe endometriosis].
Zhou J; Lei ZW; Lü JQ; Sun J; Xu XW
Zhonghua Fu Chan Ke Za Zhi; 2005 Jan; 40(1):5-8. PubMed ID: 15774083
[TBL] [Abstract][Full Text] [Related]
3. Objective evidence that placebo and oral medroxyprogesterone acetate therapy diminish menopausal vasomotor flushes.
Albrecht BH; Schiff I; Tulchinsky D; Ryan KJ
Am J Obstet Gynecol; 1981 Mar; 139(6):631-5. PubMed ID: 7211966
[TBL] [Abstract][Full Text] [Related]
4. Adenohypophyseal function in bitches treated with medroxyprogesterone acetate.
Beijerink NJ; Bhatti SF; Okkens AC; Dieleman SJ; Mol JA; Duchateau L; Van Ham LM; Kooistra HS
Domest Anim Endocrinol; 2007 Feb; 32(2):63-78. PubMed ID: 16455223
[TBL] [Abstract][Full Text] [Related]
5. Effects of steroids on basal and GnRH-induced LH and FSH secretion by dispersed pituitary cells of immature female lambs.
Peclaris GM
Endocrinol Exp; 1980 Dec; 14(4):258-68. PubMed ID: 6780307
[TBL] [Abstract][Full Text] [Related]
6. The pituitary reserve for gonadotrophins and prolactin in women under long-term use of depo-medroxyprogesterone acetate (DMPA) as a contraceptive.
Mukasa FR; Sekadde-kigondu CB; Mati JK; Njoroge JK
J Obstet Gynaecol East Cent Africa; 1982 Dec; 1(4):160-3. PubMed ID: 12313677
[TBL] [Abstract][Full Text] [Related]
7. Prevention of severe menorrhagia in oncology patients with treatment-induced thrombocytopenia by luteinizing hormone-releasing hormone agonist and depo-medroxyprogesterone acetate.
Meirow D; Rabinovici J; Katz D; Or R; Shufaro Y; Ben-Yehuda D
Cancer; 2006 Oct; 107(7):1634-41. PubMed ID: 16944540
[TBL] [Abstract][Full Text] [Related]
8. Depo-medroxyprogesterone acetate compared with conjugated estrogens for the treatment of postmenopausal women.
Lobo RA; McCormick W; Singer F; Roy S
Obstet Gynecol; 1984 Jan; 63(1):1-5. PubMed ID: 6318170
[TBL] [Abstract][Full Text] [Related]
9. Effect of thyrotropin-releasing hormone and gonadotropin-releasing hormone on serum TSH, PRL, hGH, FSH and LH in primary testicular failure and in hypogonadotrophic hypogonadism.
Szilágyi G; Szabolcs I; Vydra G; Góth M; Irsy G
Acta Med Hung; 1984; 41(4):175-83. PubMed ID: 6440114
[TBL] [Abstract][Full Text] [Related]
10. Use of medroxyprogesterone acetate to prevent menopausal symptoms.
Bullock JL; Massey FM; Gambrell RD
Obstet Gynecol; 1975 Aug; 46(2):165-8. PubMed ID: 1153148
[TBL] [Abstract][Full Text] [Related]
11. The combined pituitary function test in children: an evaluation of the clinical usefulness of TRH and LHRH stimulation tests through a retrospective analysis of one hundred and twenty six cases.
Westwood ME; Butler GE; McLellan AC; Barth JH
Clin Endocrinol (Oxf); 2000 Jun; 52(6):727-33. PubMed ID: 10848877
[TBL] [Abstract][Full Text] [Related]
12. Hormone therapy in women in the menopause transition. Randomised, double-blind, placebo-controlled trial of effects on body weight, blood pressure, lipoprotein levels, antithrombin III activity, and the endometrium.
Khoo SK; Coglan MJ; Wright GR; DeVoss KN; Battistutta D
Med J Aust; 1998 Mar; 168(5):216-20. PubMed ID: 9539899
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of depot medroxyprogesterone acetate contraception.
Mishell DR
J Reprod Med; 1996 May; 41(5 Suppl):381-90. PubMed ID: 8725700
[TBL] [Abstract][Full Text] [Related]
14. Treatment of perimenopausal women with uterine myoma: successful use of a depot GnRH agonist leading to a natural menopause.
Imai A; Sugiyama M; Furui T; Tamaya T
J Obstet Gynaecol; 2003 Sep; 23(5):518-20. PubMed ID: 12963511
[TBL] [Abstract][Full Text] [Related]
15. Subcutaneous administration of pulsatile gonadotropin-releasing hormone decreases serum follicle-stimulating hormone and luteinizing hormone levels in women with polycystic ovary syndrome: a preliminary study.
Graña-Barcia M; Liz-Lestón J; Lado-Abeal J
Fertil Steril; 2005 May; 83(5):1466-72. PubMed ID: 15866586
[TBL] [Abstract][Full Text] [Related]
16. Long-term effects of allogeneic bone marrow transplantation (BMT) on pituitary, gonad, thyroid and adrenal function in adults.
Kauppila M; Koskinen P; Irjala K; Remes K; Viikari J
Bone Marrow Transplant; 1998 Aug; 22(4):331-7. PubMed ID: 9722067
[TBL] [Abstract][Full Text] [Related]
17. Age-related decrease in hypothalamic gonadotropin-releasing hormone (GnRH) gene expression, but not pituitary responsiveness to GnRH, in the male Brown Norway rat.
Gruenewald DA; Naai MA; Marck BT; Matsumoto AM
J Androl; 2000; 21(1):72-84. PubMed ID: 10670522
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of FSH measurements for determining menopause in long-term users of depot medroxyprogesterone acetate over 40 years of age.
Juliato CT; Fernandes A; Marchi NM; Castro S; Olivotti B; Bahamondes L
Contraception; 2007 Oct; 76(4):282-6. PubMed ID: 17900438
[TBL] [Abstract][Full Text] [Related]
19. A double blind study to evaluate the effect of methyldopa on menopausal vasomotor flushes.
Hammond MG; Hatley L; Talbert LM
J Clin Endocrinol Metab; 1984 Jun; 58(6):1158-60. PubMed ID: 6725512
[TBL] [Abstract][Full Text] [Related]
20. Differences in the ratio of bioactive to immunoreactive serum luteinizing hormone during vasomotor flushes and hormonal therapy in postmenopausal women.
Chang SP; Shoupe D; Kletzky OA; Lobo RA
J Clin Endocrinol Metab; 1984 May; 58(5):925-9. PubMed ID: 6323519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
